804 related articles for article (PubMed ID: 16741055)
1. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
[TBL] [Abstract][Full Text] [Related]
2. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart.
Jesmin S; Zaedi S; Yamaguchi N; Maeda S; Shimojo N; Masuzawa K; Yamaguchi I; Goto K; Miyauchi T
Exp Biol Med (Maywood); 2006 Jun; 231(6):902-6. PubMed ID: 16741021
[TBL] [Abstract][Full Text] [Related]
4. Effects of dual endothelin receptor antagonist on antiapoptotic marker Bcl-2 expression in streptozotocin-induced diabetic rats.
Jesmin S; Zaedi S; Yamaguchi N; Maeda S; Yamaguchi I; Goto K; Miyauchi T
Exp Biol Med (Maywood); 2006 Jun; 231(6):1034-9. PubMed ID: 16741044
[TBL] [Abstract][Full Text] [Related]
5. Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat.
Ma P; Luo Y; Zhu X; Ma H; Hu J; Tang S
Biochem Biophys Res Commun; 2009 Mar; 380(2):402-6. PubMed ID: 19250642
[TBL] [Abstract][Full Text] [Related]
6. Effects of selective endothelin (ET)-A receptor antagonist versus dual ET-A/B receptor antagonist on hearts of streptozotocin-treated diabetic rats.
Miyauchi Y; Jesmin S; Sakai S; Kamiyama J; Shimojo N; Rahman A; Islam M; Zaedi S; Maeda S; Maruyama H; Mizutani T; Homma S; Aonuma K; Miyauchi T
Life Sci; 2014 Aug; 111(1-2):6-11. PubMed ID: 24953608
[TBL] [Abstract][Full Text] [Related]
7. Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats.
Jesmin S; Zaedi S; Maeda S; Yamaguchi I; Goto K; Miyauchi T
Exp Biol Med (Maywood); 2006 Jun; 231(6):925-31. PubMed ID: 16741025
[TBL] [Abstract][Full Text] [Related]
8. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451
[TBL] [Abstract][Full Text] [Related]
9. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
Hattori T; Matsubara A; Taniguchi K; Ogura Y
Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of a coumarin derivative in diabetic rats.
Bucolo C; Ward KW; Mazzon E; Cuzzocrea S; Drago F
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317
[TBL] [Abstract][Full Text] [Related]
11. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor in diabetes induced early retinal abnormalities.
Cukiernik M; Hileeto D; Evans T; Mukherjee S; Downey D; Chakrabarti S
Diabetes Res Clin Pract; 2004 Sep; 65(3):197-208. PubMed ID: 15331199
[TBL] [Abstract][Full Text] [Related]
13. [Effects of cilazapril on the expression of vascular endothelial growth factor and intercellular adhesion molecule-1 in diabetic rat glomeruli].
Lin H; Huang S; Mi X; Sha Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Oct; 34(4):694-7. PubMed ID: 14619584
[TBL] [Abstract][Full Text] [Related]
14. Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts.
Jesmin S; Zaedi S; Shimojo N; Iemitsu M; Masuzawa K; Yamaguchi N; Mowa CN; Maeda S; Hattori Y; Miyauchi T
Am J Physiol Endocrinol Metab; 2007 Apr; 292(4):E1030-40. PubMed ID: 17148754
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina.
Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913
[TBL] [Abstract][Full Text] [Related]
16. A combination of the main constituents of Fufang Xueshuantong Capsules shows protective effects against streptozotocin-induced retinal lesions in rats.
Jian W; Yu S; Tang M; Duan H; Huang J
J Ethnopharmacol; 2016 Apr; 182():50-6. PubMed ID: 26692279
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products.
Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine.
Kusari J; Zhou SX; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1044-51. PubMed ID: 19710406
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of zeaxanthin on retinal metabolic abnormalities in diabetic rats.
Kowluru RA; Menon B; Gierhart DL
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1645-51. PubMed ID: 18385086
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
Zheng Z; Chen H; Xu X; Li C; Gu Q
Exp Eye Res; 2007 Apr; 84(4):745-52. PubMed ID: 17303121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
